The global respiratory care devices market is estimated to value over USD 32 billion and register a CAGR value of over 8% from the forecast period 2019 to 2026.

The rapid growth of the healthcare segment coupled with the growing geriatric population is driving the growth of the market. Increasing cases of tobacco smoking alongside cases of preterm birth is also propelling the market. Furthermore, the introduction of enhanced and efficient portable respiratory devices is accelerating market growth. The growing adoption of multimodal ventilators is anticipated to fuel the market. According to the Center for Disease Control and Prevention (CDC), more than 15 million people in America suffer from smoking-related diseases such as lung diseases, COPD, heart diseases. Such rise in the patient population is expected to strengthen the market. Rising adoption of non-invasive ventilation is bolstering the market as well. Moreover, rapid usage of compact respiratory care devices is fueling the growth of the market. The growth of point-of-care diagnostics is expected to create new opportunities for manufacturers.

The market is bifurcated into product, indication and end-user. Product type consists of therapeutic devices, monitoring devices, consumables & accessories, and diagnostic devices. Therapeutic devices segment is anticipated to witness substantial growth during the forecast period. The growing air pollution and causes of chronic diseases remain the key factors accelerating the demand for therapeutics devices. The therapeutic devices are further segmented into humidifiers, inhalers, ventilators, positive airway pressure (PAP) devices, reusable resuscitators. Positive airway pressure is expected to be in vast demand owing to growing cases of obstructive sleep apnea. The efficient supply system in regions like Europe and the US is mainly driving the market.

In terms of end-users, hospitals are expected to dominate the market growth. The financial capabilities of hospitals allows to purchase advanced instruments and acquire trained professionals. 

Based on regions, North America is expected to dictate the growth of the market. The presence of prominent players alongside the growing geriatric population is bolstering the market in the region. Furthermore, the rise in disposable income is positively influencing the market in the region. The rising healthcare expenditure alongside the expansion of the healthcare industry is stimulating the market as well.   Asia-Pacific region is expected to witness notable growth owing to the government investments for developed healthcare infrastructure and rising at-home diagnostics service. Growing demand for advanced technologies alongside increasing investments in the healthcare sector is boosting the presence of the market in the region. Rising patient pool due to respiratory diseases and rise in per capita income are also key factors boosting the presence of the market in the region.

Prominent players of the market are ResMed Inc., Drager AG, Getinge AB, Hamilton  AG, Apex Medical Corp., DeVilbiss Healthcare LLC, Teleflex Incorporated, Nonin Medical Inc., Chart Industries, Fisher & Paykel Healthcare Corporation Limited and Vyaire Medical.

Additional Insights:

• Technological advancements in the form of E-Nose and enhanced portable respiratory devices will play a major role in strengthening the market during the forecast period
• Mergers and acquisitions among major players will boost the market as well.

Global Respiratory Care Devices Market Segmentation

By Product

● Therapeutic Devices
o PAP Devices
o Ventilators
o Nebulizers
o Humidifiers
o Oxygen Concentrators
o Inhalers
o Reusable Resuscitators
o Nitric Oxide Delivery Units
o Oxygen Hoods

● Monitoring Devices
o Pulse Oximeters
o Capnographs
o Gas Analyzers

● Diagnostic Devices
o Spirometers
o Polysomnography Devices
o Peak Flow Meters
o Other Diagnostic Devices

● Consumables and Accessories
o Masks
o Reusable Masks
o Nasal Masks
o Full-face Masks
o Nasal pillow masks
o Oral Masks
o Disposable Mask
o Disposable Resuscitators
o Tracheostomy Tubes
o Nasal Cannulas
o Other Consumables and Accessories

By Indication

• Chronic Obstructive Pulmonary Disease (COPD)
• Asthma
• Sleep Apnea
• Infectious Disease
• Other diseases

By End-User

• Hospitals
• Home Care Settings
• Ambulatory Care Centers

By Region

• North America 
• Europe
• Asia Pacific 
• Latin America 
• Middle East & Africa

Competitive Landscape: 

• Mergers and Acquisitions are bolstering the market. ResMed in 2019, acquired HB Healthcare Safety. The move bolstered the supply of respiratory care devices and home-based medical equipment for sleep
• Masimo Corporation collaborated with Shenzhen Mindray Bio-Medical Electronics to offer low perfusion pulse oximetry in their monitoring devices.

FutureWise Key Takeaways

• Growth Prospects
• SWOT Analysis
• Key Trends
• Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global respiratory care devices market by product, by indication, by end-user and by region 

•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

•    To evaluate and forecast micro-markets and the overall market 

•    To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East  & Africa

•    To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

•    Profiling of companies to evaluate their market shares, strategies, financial and core competencies 

Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com